Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 356

1.

Simple and cost-effective assay for isolating invasive living cells.

Takino T, Sato H, Seiki M.

Biotechniques. 2018 Sep;65(3):137-142. doi: 10.2144/btn-2018-0036.

2.

MT4-MMP deficiency increases patrolling monocyte recruitment to early lesions and accelerates atherosclerosis.

Clemente C, Rius C, Alonso-Herranz L, Martín-Alonso M, Pollán Á, Camafeita E, Martínez F, Mota RA, Núñez V, Rodríguez C, Seiki M, Martínez-González J, Andrés V, Ricote M, Arroyo AG.

Nat Commun. 2018 Mar 2;9(1):910. doi: 10.1038/s41467-018-03351-4.

3.

Identification of Proteolytic Cleavage Sites of EphA2 by Membrane Type 1 Matrix Metalloproteinase on the Surface of Cancer Cells.

Kikuchi K, Kozuka-Hata H, Oyama M, Seiki M, Koshikawa N.

Methods Mol Biol. 2018;1731:29-37. doi: 10.1007/978-1-4939-7595-2_3.

PMID:
29318540
4.

Specific detection of soluble EphA2 fragments in blood as a new biomarker for pancreatic cancer.

Koshikawa N, Minegishi T, Kiyokawa H, Seiki M.

Cell Death Dis. 2017 Oct 26;8(10):e3134. doi: 10.1038/cddis.2017.545.

5.

Development of a fully automated chemiluminescence immunoassay for urine monomeric laminin-γ2 as a promising diagnostic tool of non-muscle invasive bladder cancer.

Nakagawa M, Karashima T, Kamada M, Yoshida E, Yoshimura T, Nojima M, Inoue K, Shuin T, Seiki M, Koshikawa N.

Biomark Res. 2017 Oct 13;5:29. doi: 10.1186/s40364-017-0109-4. eCollection 2017.

6.

Developmental expression of membrane type 4-matrix metalloproteinase (Mt4-mmp/Mmp17) in the mouse embryo.

Blanco MJ, Rodríguez-Martín I, Learte AIR, Clemente C, Montalvo MG, Seiki M, Arroyo AG, Sánchez-Camacho C.

PLoS One. 2017 Sep 19;12(9):e0184767. doi: 10.1371/journal.pone.0184767. eCollection 2017.

7.

Therapy with transcutaneous administration of imiquimod combined with oral administration of sorafenib suppresses renal cell carcinoma growing in an orthotopic mouse model.

Karashima T, Udaka K, Niimura M, Suzuki K, Osakabe H, Shimamoto T, Fukata S, Inoue K, Kuroda N, Seiki M, Shuin T.

Oncol Lett. 2017 Jul;14(1):1162-1166. doi: 10.3892/ol.2017.6235. Epub 2017 May 24.

8.

Mint3 in bone marrow-derived cells promotes lung metastasis in breast cancer model mice.

Hara T, Murakami Y, Seiki M, Sakamoto T.

Biochem Biophys Res Commun. 2017 Aug 26;490(3):688-692. doi: 10.1016/j.bbrc.2017.06.102. Epub 2017 Jun 19.

PMID:
28634075
9.

Control of metastatic niche formation by targeting APBA3/Mint3 in inflammatory monocytes.

Hara T, Nakaoka HJ, Hayashi T, Mimura K, Hoshino D, Inoue M, Nagamura F, Murakami Y, Seiki M, Sakamoto T.

Proc Natl Acad Sci U S A. 2017 May 30;114(22):E4416-E4424. doi: 10.1073/pnas.1703171114. Epub 2017 May 15.

10.

Mint3-mediated L1CAM expression in fibroblasts promotes cancer cell proliferation via integrin α5β1 and tumour growth.

Nakaoka HJ, Tanei Z, Hara T, Weng JS, Kanamori A, Hayashi T, Sato H, Orimo A, Otsuji K, Tada K, Morikawa T, Sasaki T, Fukayama M, Seiki M, Murakami Y, Sakamoto T.

Oncogenesis. 2017 May 15;6(5):e334. doi: 10.1038/oncsis.2017.27.

11.

Serum monomeric laminin-γ2 as a novel biomarker for hepatocellular carcinoma.

Kiyokawa H, Yasuda H, Oikawa R, Okuse C, Matsumoto N, Ikeda H, Watanabe T, Yamamoto H, Itoh F, Otsubo T, Yoshimura T, Yoshida E, Nakagawa M, Koshikawa N, Seiki M.

Cancer Sci. 2017 Jul;108(7):1432-1439. doi: 10.1111/cas.13261. Epub 2017 Jun 2.

12.

Integrated functions of membrane-type 1 matrix metalloproteinase in regulating cancer malignancy: Beyond a proteinase.

Sakamoto T, Seiki M.

Cancer Sci. 2017 Jun;108(6):1095-1100. doi: 10.1111/cas.13231. Epub 2017 May 22. Review.

13.

Mint3/Apba3 depletion ameliorates severe murine influenza pneumonia and macrophage cytokine production in response to the influenza virus.

Uematsu T, Fujita T, Nakaoka HJ, Hara T, Kobayashi N, Murakami Y, Seiki M, Sakamoto T.

Sci Rep. 2016 Nov 24;6:37815. doi: 10.1038/srep37815.

14.

Mint3 potentiates TLR3/4- and RIG-I-induced IFN-β expression and antiviral immune responses.

Huai W, Song H, Yu Z, Wang W, Han L, Sakamoto T, Seiki M, Zhang L, Zhang Q, Zhao W.

Proc Natl Acad Sci U S A. 2016 Oct 18;113(42):11925-11930. Epub 2016 Oct 3.

15.

New insight into the role of MMP14 in metabolic balance.

Mori H, Bhat R, Bruni-Cardoso A, Chen EI, Jorgens DM, Coutinho K, Louie K, Bowen BB, Inman JL, Tecca V, Lee SJ, Becker-Weimann S, Northen T, Seiki M, Borowsky AD, Auer M, Bissell MJ.

PeerJ. 2016 Jul 13;4:e2142. doi: 10.7717/peerj.2142. eCollection 2016.

16.

The ERK signaling target RNF126 regulates anoikis resistance in cancer cells by changing the mitochondrial metabolic flux.

Yoshino S, Hara T, Nakaoka HJ, Kanamori A, Murakami Y, Seiki M, Sakamoto T.

Cell Discov. 2016 Jul 26;2:16019. doi: 10.1038/celldisc.2016.19. eCollection 2016.

17.

Cortactin promotes exosome secretion by controlling branched actin dynamics.

Sinha S, Hoshino D, Hong NH, Kirkbride KC, Grega-Larson NE, Seiki M, Tyska MJ, Weaver AM.

J Cell Biol. 2016 Jul 18;214(2):197-213. doi: 10.1083/jcb.201601025. Epub 2016 Jul 11.

18.

NECAB3 Promotes Activation of Hypoxia-inducible factor-1 during Normoxia and Enhances Tumourigenicity of Cancer Cells.

Nakaoka HJ, Hara T, Yoshino S, Kanamori A, Matsui Y, Shimamura T, Sato H, Murakami Y, Seiki M, Sakamoto T.

Sci Rep. 2016 Mar 7;6:22784. doi: 10.1038/srep22784.

19.

Matrix metalloproteinase-14 mediates formation of bile ducts and hepatic maturation of fetal hepatic progenitor cells.

Otani S, Kakinuma S, Kamiya A, Goto F, Kaneko S, Miyoshi M, Tsunoda T, Asano Y, Kawai-Kitahata F, Nitta S, Nakata T, Okamoto R, Itsui Y, Nakagawa M, Azuma S, Asahina Y, Yamaguchi T, Koshikawa N, Seiki M, Nakauchi H, Watanabe M.

Biochem Biophys Res Commun. 2016 Jan 22;469(4):1062-8. doi: 10.1016/j.bbrc.2015.12.105. Epub 2015 Dec 24.

PMID:
26724533
20.

Matrix metalloproteinase 14 modulates signal transduction and angiogenesis in the cornea.

Chang JH, Huang YH, Cunningham CM, Han KY, Chang M, Seiki M, Zhou Z, Azar DT.

Surv Ophthalmol. 2016 Jul-Aug;61(4):478-97. doi: 10.1016/j.survophthal.2015.11.006. Epub 2015 Dec 2. Review.

PMID:
26647161

Supplemental Content

Support Center